Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 2 ( March-April, 2019 ) > List of Articles


Making Magnesium Sulfate Therapy Safer in Eclampsia: A Comparative Study of Zuspan Regime vs Low-dose Intravenous MgSO4 Regime

Smruti B Vaishnav, Nitin Raithatha, Krina Kathawadia, Ajay Phatak, Nipa Modi, Rakhee Patel

Keywords : Eclampsia, Low maintenance dose regime, Magnesium sulfate, Maternal mortality, Zuspan regime

Citation Information : Vaishnav SB, Raithatha N, Kathawadia K, Phatak A, Modi N, Patel R. Making Magnesium Sulfate Therapy Safer in Eclampsia: A Comparative Study of Zuspan Regime vs Low-dose Intravenous MgSO4 Regime. J South Asian Feder Obs Gynae 2019; 11 (2):126-130.

DOI: 10.5005/jp-journals-10006-1675

License: CC BY-NC 4.0

Published Online: 01-06-2019

Copyright Statement:  Copyright © 2019; The Author(s).


Objective: Magnesium sulfate is a universally accepted drug for the control of convulsions in eclampsia. Regimes available have been well tried in western countries where the weight of women is much higher than Indian women. In the present study, we tried to compare the doses used in zuspan regime (used previously in our hospital) with the regime where we reduced the maintenance dose to half for average weight women of the rural area (≤50 kg). Design: A PRE-POST comparative study of 2 regimes of magnesium sulfate therapy in cases of eclampsia. Setting: Tertiary care center in the low-resource rural area of central Gujarat. Population: Group I: All patients of eclampsia, March 2007 to April 2012. Group II: All patients with eclampsia who were weighing ≤50 kg (BMI ≤25) May 2012–Oct 2013. Materials and methods: Group I: Zuspan regime: Loading dose 4 g intravenously 20% over 20 minutes and maintenance dose 1 g/hour intravenously. Group II: Low maintenance dose regime: Loading dose: 4 g intravenously 20% over 20 minutes and maintenance dose: 0.5 g/hour. Main outcome measures: Rates of recurrence of convulsions, magnesium sulfate toxicity, and maternal mortality. Results: Recurrent convulsion rate was 5% in group I and 9.6% in group II. Toxicity was seen in 15.3% of cases in group I while it was not seen in group II. Maternal mortality in group I was 1.5% and no mortality in group II. Conclusion: A low maintenance dose of magnesium sulfate is safe and effective for controlling convulsions in patients with eclampsia weighing ≤50 kg.

  1. Liu S, Joseph KS, et al. Maternal Health Study Group of Canadian Perinatal Surveillance System Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol 2011;118(5):987. DOI: 10.1097/AOG.0b013e31823311c1.
  2. Sibai BM. Disparity in the rate of eclampsia and adverse pregnancy outcome from eclampsia: a tale of two countries. Obstet Gynecol 2011 Nov;118(5):976–977. DOI: 10.1097/AOG.0b013e31823556c6.
  3. Gupte S. Report on eclampsia registry updated on march 2014; available at
  4. Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from collaborative eclampsia trial. Lancet 1995 June 10;345(8963):1455–1463. DOI: 10.1016/S0140-6736(95)91034-4.
  5. Duley L, Henderson-Smart DJ. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 1995;346(4):P1365.
  6. Duley L, Gulmezoglu AM. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev 2000;(1):CD002960.
  7. Duley L, Henderson-Smart DJ. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2000;(4):CD000127.
  8. Duley L, Matar HE, et al. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. The Cochrane Library 2010(8):CD007388.
  9. Pritchard JA, Cunningham FC, et al. The Parkland memorial hospital protocol for treatment of Eclampsia. AM J Obstet Gynecol 1984;148(7):951–963. DOI: 10.1016/0002-9378(84)90538-6.
  10. Zuspan FP. Problems encountered in the Treatment of Pregnancy-induced Hypertension. Am J Obstet Gyencol 1978;131(6):591–596. DOI: 10.1016/0002-9378(78)90816-5.
  11. Sibai BM, Graham JM, et al. Comparision of intravenous and intramuscular magnesium sulphate regimens in Preeclampsia. Am J Obstet Gynecol 1984;150:728.
  12. Bhattacharjee N, Saha SP, et al. A randomised comparative study between low-dose intravenous magnesium sulphate and standard intramuscular regimen for treatment of eclampsia. Journal of Obstetrics & Gynaecology May 2011;31(4):298–303.
  13. Cunningham F, Leveno K, et al. Williams obstetrics. 23rd ed., pp. 706–756.
  14. Joshi Suyajna D, Veerendrakumar CM. Single Dose MgSO4 Regimen for Eclampsia- A Safe Motherhood Initiative. J Clin Diagn Res 2013 May;7(5):868–872.
  15. Suman S, Shivanjali M, et al. Low dose magnesium sulphate for eclampsia and imminent eclampsia: regimen tailored for tropical women. J Obstet Gynaecol Ind 2003;53:546–550.
  16. Begum R, Begum A, et al. A low dose (“Dhaka”) magnesium sulphate regime for eclampsia. Acta Obstet Gynecol Scand 2001 Nov; 80(11):998–1002.
  17. Dayicioglu V, Sahinoalu Z, et al. The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: Do body mass index alterations have any effect on success? Hypertension in Pregnancy 2003;22(3):257–265. DOI: 10.1081/PRG- 120024029.
  18. Chisel S, Botha JH, et al. Intravenous and intramuscular magnesium sulphate regimens in sever preeclampsia. A Afr Med J 1994 Sep;84(9):607–610.
  19. Salinger DH, Mundle S, et al. Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenousregimens equivalent? A population pharmacokinetic study. BJOG 2013 Jun;120(7):8. DOI: 10.1111/1471-0528.12222.
  20. Mahajan NN, Thomas A, et al. Padhar Regime’ – A Low-Dose Magnesium sulphate Treatment for Eclampsia. Gynecol Obstet Invest 2009;67:20–24. DOI: 10.1159/000158647.
  21. Singh S, Behera A. Eclampsia In Eastearn India: Incidence, Demographic Profile and Response to Three Different Anticonvulsants Regimes of Magnesium Sulfate. The Internet Journal of Gynecology and Obstetrics 2011;15(2):1–7.
  22. Sunita TH, Rathnamala M. Desai Eclampsia in a Teaching Hospital: Incidence, Clinical Profile, and response to Magnesium sulphate by Zuspan's regimen. J Dent and Med Sci Jan–Feb 2013;4(2):1–5.
  23. Bhalla AK, Dhall GI, et al. A safer and more effective treatment regimen for eclampsia. Aust NZ J Obstet Gynaecol 1994;34(2):144–148. DOI: 10.1111/j.1479-828X.1994.tb02677.x.
  24. Sibai BM, Lipshitz J, et al. Reassessments of intravenous MgSO4 therapy in pre-eclampsia. Obstet Gynecol 1981;57:199.
  25. Koos BJ, Purcell KJ. Judicious use of magnesium sulphate for eclampsia. OBG management June 2003;15(6):38–56.
  26. Kathleen M. Grahama, Magnesium sulphate in eclampsia. The Lancet April 1998;351(9108):1061.
  27. Jana N, Dasgupta S, et al. Experience of a low-dose magnesium sulfate regimen for the management of eclampsia over a decade. Int J Gynaecol Obstet 2013;122(1):13–17. DOI: 10.1016/j.ijgo.2013. 01.029.
  28. Chowdhury JR, Chaudhuri S, et al. Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia. N J Obstet Gynaecol Res 2009;35(1):119–125.
  29. Ekele BA, Muhammed D, et al. Magnesium sulphate therapy in eclampsia: the Sokoto (ultrashort) regimen. BMC Research Notes 2009;2:165. DOI: 10.1186/1756-0500-2-165.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.